How Can SPS-MS3 Be Utilized to Optimize TMT Workflows and Minimize Ratio Compression?
- In-depth quantification of complex tissue samples, such as tumor tissue and brain tissue, with high molecular complexity.
- Low-abundance protein research: Including transcription factors, cytokines, and other proteins expressed at low levels.
- Clinical biomarker discovery: Particularly suitable for multi-omics clinical studies that demand exceptionally high quantitative accuracy.
- Drug mechanism studies: Characterizing protein regulatory changes before and after pharmacological interventions.
Tandem Mass Tags (TMT) are an isotope-labeling technology widely employed in high-throughput quantitative proteomics, enabling parallel analysis of multiple samples (currently supporting up to 18-plex). This approach has demonstrated substantial advantages in elucidating disease mechanisms, understanding drug modes of action, and identifying clinical biomarkers. However, ratio compression remains one of the most critical technical bottlenecks in TMT quantification. Co-eluting peptides at the MS2 stage introduce interference, causing inaccurate measurement of reporter ion intensities for target peptides and leading to underestimation of quantitative values, an effect particularly evident for low-abundance proteins. To address this issue, Synchronous Precursor Selection-MS3 (SPS-MS3) has been developed and has progressively become one of the core strategies for achieving high-precision TMT quantification.
Causes of Ratio Compression: Insights from the MS2 Stage
In the TMT-MS2 workflow, peptide precursor ions are selected at the first stage of mass spectrometry (MS1) and subjected to either collision-induced dissociation (CID) or higher-energy collision dissociation (HCD). At this stage, co-isolated precursor ions are often present alongside the target peptides. These non-target ions also undergo fragmentation in MS2, releasing reporter ions derived from non-target peptides. This contamination of the reporter ion signal distorts quantification and compresses the true expression ratios.
Principles and Advantages of SPS-MS3
1. What Is SPS-MS3?
SPS-MS3 is an advanced quantification method implemented on the Orbitrap Tribrid platform (e.g., Fusion Lumos, Eclipse) that selects multiple fragment ions from MS2 for simultaneous isolation and fragmentation in MS3. This strategy substantially mitigates the impact of co-eluting interference.
Workflow:
(1) MS1: Selection of precursor ions corresponding to target peptides
(2) MS2: Initial fragmentation, producing a series of b/y ions (fragment ions generated by peptide backbone cleavage)
(3) SPS Selection: Isolation of multiple high-intensity b/y ions from the MS2 spectrum (typically 10 ions)
(4) MS3: High-energy fragmentation of the SPS-selected ions to generate TMT reporter ions for quantification
2. Key Advantages of SPS-MS3
(1) Significant Reduction of Ratio Compression: Quantification based on multiple MS2 fragment ions rather than the original precursor effectively eliminates contributions from co-eluting contaminants.
(2) Enhanced Quantification Accuracy and Reliability: Particularly advantageous for detecting differential expression in low-abundance proteins.
(3) Improved Reproducibility: Provides stable quantitative performance across replicate experiments.
Strategies for Optimizing the TMT Workflow to Maximize SPS-MS3 Performance
1. Instrument Parameter Optimization
(1) Number of SPS Ions: Select 8–10 high-intensity MS2 fragment ions as SPS ions, avoiding low-intensity or background peaks.
(2) MS3 Resolution: Set Orbitrap resolution to at least 60,000 at m/z 200 to ensure accurate separation of TMT reporter ions.
(3) Normalized Collision Energy (NCE): Use a relatively high NCE (e.g., 65–70%) in the MS3 stage to ensure efficient release of reporter ions.
2. Sample Preparation Optimization
(1) High-pH Reverse-Phase Fractionation (HpH Fractionation): Reduces sample complexity and lowers the likelihood of co-elution.
(2) Protease Digestion Efficiency: Maintain complete and specific proteolysis to reduce background interference.
(3) Removal of High-Abundance Proteins: For plasma or tissue samples, deplete albumin, immunoglobulins, and other high-abundance proteins prior to analysis.
3. Data Analysis Strategies
(1) Integrate Proteome Discoverer with SEQUEST or Byonic, coupled with the SPS-MS3 quantification module.
(2) Apply the precursor coisolation threshold to evaluate interference levels.
(3) Filter peptides based on reporter ion signal-to-noise ratio (S/N) to improve data quality.
Application Scenarios for SPS-MS3
TMT is a powerful platform for high-throughput proteomics, yet its full potential for multiplexed quantification can only be realized by addressing ratio compression. SPS-MS3 offers a robust and reliable solution, particularly suited for highly complex samples and subtle differential expression studies. MtoZ Biolabs is dedicated to safeguarding the integrity of every experimental dataset. If you are performing TMT quantification experiments or facing challenges with ratio compression, please reach out to our expert team for personalized technical support and tailored solutions.
MtoZ Biolabs, an integrated chromatography and mass spectrometry (MS) services provider.
Related Services
How to order?
